Letitia E Bible1, Latha V Pasupuleti, Amy V Gore, Ziad C Sifri, Kolenkode B Kannan, Alicia M Mohr. 1. From the Division of Trauma (L.E.B., L.V.P., A.V.G., Z.C.S.), Department of Surgery, Rutgers-New Jersey Medical School, Newark, New Jersey; and Division of Acute Care Surgery (K.B.K., A.M.M.), Department of Surgery, University of Florida, Gainesville, Florida.
Abstract
BACKGROUND: Following severe traumatic injury, critically ill patients have a prolonged hypercatacholamine state that is associated with bone marrow (BM) dysfunction and persistent anemia. However, current animal models of injury and shock result in a transient anemia. Daily restraint stress (chronic stress [CS]) has been shown to increase catecholamines. We hypothesize that adding CS following injury or injury and shock in rats will prolong the hypercatecholaminemia and prolong the initial anemia, despite elevated erythropoietin (EPO) levels. METHODS: Male Sprague-Dawley rats (n = 6-8 per group) underwent lung contusion (LC) or combined LC/hemorrhagic shock (LCHS) followed by 6 days of CS. CS consisted of a 2-hour restraint period interrupted with repositioning and alarms every 30 minutes. At 7 days, urine was assessed for norepinephrine (NE) levels, blood for EPO and hemoglobin (Hgb), and BM for erythroid progenitor growth. RESULTS: Animals undergoing LC or combined LCHS predictably recovered by Day 7; urine NE, EPO, and Hgb levels were normal. The addition of CS to LC and LCHS models was associated with a significant elevation in NE on Day 6. The addition of CS to LC led to a persistent 20% to 25% decrease in the growth of BM hematopoietic progenitor cells. These findings were further exaggerated when CS was added following LCHS, resulting in a 20%q to 40% reduction in BM erythroid progenitor colony growth and a 20% decrease in Hgb when compared with LCHS alone. CONCLUSION: Exposing injured animals to CS results in prolonged elevation of NE and EPO, which is associated with worsening BM erythroid function and persistent anemia. Chronic restraint stress following injury and shock provides a clinically relevant model to further evaluate persistent injury-associated anemia seen in critically ill trauma patients. Furthermore, alleviating CS after severe injury is a potential therapeutic target to improve BM dysfunction and anemia.
BACKGROUND: Following severe traumatic injury, critically illpatients have a prolonged hypercatacholamine state that is associated with bone marrow (BM) dysfunction and persistent anemia. However, current animal models of injury and shock result in a transient anemia. Daily restraint stress (chronic stress [CS]) has been shown to increase catecholamines. We hypothesize that adding CS following injury or injury and shock in rats will prolong the hypercatecholaminemia and prolong the initial anemia, despite elevated erythropoietin (EPO) levels. METHODS: Male Sprague-Dawley rats (n = 6-8 per group) underwent lung contusion (LC) or combined LC/hemorrhagic shock (LCHS) followed by 6 days of CS. CS consisted of a 2-hour restraint period interrupted with repositioning and alarms every 30 minutes. At 7 days, urine was assessed for norepinephrine (NE) levels, blood for EPO and hemoglobin (Hgb), and BM for erythroid progenitor growth. RESULTS: Animals undergoing LC or combined LCHS predictably recovered by Day 7; urine NE, EPO, and Hgb levels were normal. The addition of CS to LC and LCHS models was associated with a significant elevation in NE on Day 6. The addition of CS to LC led to a persistent 20% to 25% decrease in the growth of BM hematopoietic progenitor cells. These findings were further exaggerated when CS was added following LCHS, resulting in a 20%q to 40% reduction in BM erythroid progenitor colony growth and a 20% decrease in Hgb when compared with LCHS alone. CONCLUSION: Exposing injured animals to CS results in prolonged elevation of NE and EPO, which is associated with worsening BM erythroid function and persistent anemia. Chronic restraint stress following injury and shock provides a clinically relevant model to further evaluate persistent injury-associated anemia seen in critically ill traumapatients. Furthermore, alleviating CS after severe injury is a potential therapeutic target to improve BM dysfunction and anemia.
Authors: John Hunzeker; David A Padgett; Patricia A Sheridan; Firdaus S Dhabhar; John F Sheridan Journal: Brain Behav Immun Date: 2004-11 Impact factor: 7.217
Authors: Timothy S Walsh; Robert J Lee; Caroline R Maciver; Magnus Garrioch; Fiona Mackirdy; Alexander R Binning; Stephen Cole; D Brian McClelland Journal: Intensive Care Med Date: 2005-11-23 Impact factor: 17.440
Authors: Elisabeth Schraml; Robert Fuchs; Petra Kotzbeck; Johannes Grillari; Konrad Schauenstein Journal: Stem Cells Dev Date: 2009-03 Impact factor: 3.272
Authors: Howard L Corwin; Andrew Gettinger; Ronald G Pearl; Mitchell P Fink; Mitchell M Levy; Edward Abraham; Neil R MacIntyre; M Michael Shabot; Mei-Sheng Duh; Marc J Shapiro Journal: Crit Care Med Date: 2004-01 Impact factor: 7.598
Authors: Patsy R Carter; Megan N Watts; Melissa Kosloski-Davidson; Kanchanjunga Prasai; Matthew B Grisham; Norman R Harris Journal: Inflamm Bowel Dis Date: 2013-05 Impact factor: 5.325
Authors: Willem-Peter T Ruifrok; Cheng Qian; Herman H W Silljé; Harry van Goor; Dirk J van Veldhuisen; Wiek H van Gilst; Rudolf A de Boer Journal: J Mol Med (Berl) Date: 2010-12-30 Impact factor: 4.599
Authors: Ines G Alamo; Kolenkode B Kannan; Michael A Smith; Philip A Efron; Alicia M Mohr Journal: J Trauma Acute Care Surg Date: 2016-10 Impact factor: 3.313
Authors: Getasha D Doobay; Elizabeth S Miller; Camille G Apple; Tyler J Loftus; Kolenkode B Kannan; Philip A Efron; Alicia M Mohr Journal: J Surg Res Date: 2020-12-26 Impact factor: 2.192
Authors: Jessica K Millar; Kolenkode B Kannan; Tyler J Loftus; Ines G Alamo; Jessica Plazas; Philip A Efron; Alicia M Mohr Journal: J Surg Res Date: 2017-03-31 Impact factor: 2.192
Authors: Ines G Alamo; Kolenkode B Kannan; Letitia E Bible; Tyler J Loftus; Harry Ramos; Philip A Efron; Alicia M Mohr Journal: J Trauma Acute Care Surg Date: 2017-04 Impact factor: 3.313
Authors: Ines G Alamo; Kolenkode B Kannan; Harry Ramos; Tyler J Loftus; Philip A Efron; Alicia M Mohr Journal: Surgery Date: 2016-10-11 Impact factor: 3.982
Authors: Elizabeth S Miller; Tyler J Loftus; Kolenkode B Kannan; Jessica M Plazas; Philip A Efron; Alicia M Mohr Journal: J Surg Res Date: 2019-06-14 Impact factor: 2.192
Authors: Tyler J Loftus; Kolenkode B Kannan; Christy S Carter; Jessica M Plazas; Juan C Mira; Scott C Brakenridge; Christiaan Leeuwenburgh; Philip A Efron; Alicia M Mohr Journal: J Trauma Acute Care Surg Date: 2018-03 Impact factor: 3.313
Authors: Tyler J Loftus; Kolenkode B Kannan; Christy S Carter; Jessica M Plazas; Juan C Mira; Scott C Brakenridge; Christiaan Leeuwenburgh; Philip A Efron; Alicia M Mohr Journal: Exp Gerontol Date: 2018-01-04 Impact factor: 4.032
Authors: Elizabeth S Miller; Camille G Apple; Kolenkode B Kannan; Zackary M Funk; Philip A Efron; Alicia M Mohr Journal: Am J Surg Date: 2020-07-25 Impact factor: 2.565